Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

Voronoi310210

Voronoi (310210) Amended Material Information, Nov 10, 2026

Filing date ·

Voronoi corrected the target number of subjects for its VRN110755 Phase 1/2 clinical trial from about 255 to about 355.

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists and official source links are available without signing in.